Edition:
India

Abiomed Inc (ABMD.OQ)

ABMD.OQ on NASDAQ Stock Exchange Global Select Market

305.92USD
20 Apr 2018
Change (% chg)

$-0.53 (-0.17%)
Prev Close
$306.45
Open
$306.01
Day's High
$307.10
Day's Low
$303.02
Volume
109,130
Avg. Vol
148,079
52-wk High
$308.82
52-wk Low
$122.84

Chart for

About

ABIOMED, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company operates in the segment of the research, development and sale of medical devices to assist or replace the pumping function of the failing heart. The Company develops,... (more)

Overall

Beta: 0.21
Market Cap(Mil.): $7,712.59
Shares Outstanding(Mil.): 44.10
Dividend: --
Yield (%): --

Financials

BRIEF-Abiomed Announces European Approval For Impella 5.5(Tm)

* ABIOMED ANNOUNCES EUROPEAN APPROVAL (CE MARKING) FOR IMPELLA 5.5(TM) AND FIRST PATIENT TREATED AT UNIVERSITY HEART CENTER HAMBURG Source text for Eikon: Further company coverage:

05 Apr 2018

BRIEF-Abiomed Announces European Approval (CE Marking) For Impella 5.5™

* ABIOMED ANNOUNCES EUROPEAN APPROVAL (CE MARKING) FOR IMPELLA 5.5™ AND FIRST PATIENT TREATED AT UNIVERSITY HEART CENTER HAMBURG Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

04 Apr 2018

BRIEF-Abiomed Receives FDA Approval For Impella Cp® With Smartassist™ And Optical Sensor

* ABIOMED RECEIVES FDA APPROVAL FOR IMPELLA CP® WITH SMARTASSIST™ AND OPTICAL SENSOR

02 Apr 2018

BRIEF-Abiomed To Appoint Todd Trapp Chief Financial Officer

* ABIOMED TO APPOINT NEW CHIEF FINANCIAL OFFICER TODD A. TRAPP

30 Mar 2018

Abiomed to pay $3.1 million to settle case over lavish doctor meals

BOSTON Abiomed Inc has agreed to pay $3.1 million to resolve a U.S. probe into allegations that it sought to get doctors to use a line of heart pumps it produced by buying them lavish meals at some of the most expensive restaurants in the United States.

09 Mar 2018

UPDATE 2-Abiomed to pay $3.1 mln to settle case over lavish doctor meals

BOSTON, March 8 Abiomed Inc has agreed to pay $3.1 million to resolve a U.S. probe into allegations that it sought to get doctors to use a line of heart pumps it produced by buying them lavish meals at some of the most expensive restaurants in the United States.

09 Mar 2018

BRIEF-Abiomed Says Entered Settlement With U.S. DoJ Resolving Claims Related To Employee Meals

* ABIOMED - ON MARCH 6, ENTERED SETTLEMENT WITH U.S. DOJ RESOLVING CLAIMS ON CO'S REIMBURSEMENT OF EMPLOYEE EXPENSES FOR MEALS WITH HEALTHCARE PROVIDERS Source text: (http://bit.ly/2G9t6b6) Further company coverage:

09 Mar 2018

Heart pump maker Abiomed settles U.S. kickback probe for $3.1 mln

BOSTON, March 8 Abiomed Inc has agreed to pay $3.1 million to resolve a U.S. investigation into allegations that it sought to induce doctors into using a line of heart pumps it produced by buying them lavish meals.

08 Mar 2018

BRIEF-Abiomed Receives Approval For Expanded FDA Indication For High Risk PCI Procedures

* ABIOMED RECEIVES APPROVAL FOR EXPANDED FDA INDICATION FOR HIGH RISK PERCUTANEOUS CORONARY INTERVENTION (PCI) PROCEDURES Source text for Eikon: Further company coverage:

14 Feb 2018

BRIEF-Abiomed Receives Approval For Expanded FDA Indication For Cardiomyopathy With Cardiogenic Shock

* ABIOMED RECEIVES APPROVAL FOR EXPANDED FDA INDICATION FOR CARDIOMYOPATHY WITH CARDIOGENIC SHOCK

13 Feb 2018

Earnings vs. Estimates